Michael Patrick Achiam

Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial

John V. Reynolds, Shaun R. Preston, Brian Patrick O’Neill et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 173 citations · Full text

Medicine, Oncology, Perioperative Medicine +16

Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial

Rahim M. Naimi, Mark Hvistendahl, Lotte Hahn Enevoldsen et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 75 citations

Medicine, Endocrinology, Pharmacology +8

Continuous monitoring of vital sign abnormalities; association to clinical complications in 500 postoperative patients

Camilla Haahr-Raunkjær, Jesper Mølgaard, Søren M. Rasmussen et al. · Acta Anaesthesiologica Scandinavica · 2022 · 67 citations · Full text

Medicine, Perioperative Medicine, Surgery +17

Continuous vital sign monitoring after major abdominal surgery—Quantification of micro events

C. L. Duus, Eske Kvanner Aasvang, Rasmus Munch Olsen et al. · Acta Anaesthesiologica Scandinavica · 2018 · 60 citations · Full text

Medicine, Perioperative Medicine, Surgery +17

International variation in oesophageal and gastric cancer survival 2012–2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study)

Melina Arnold, Eileen Morgan, Aude Bardot et al. · Gut · 2021 · 56 citations · Full text

Medicine, Oncology, Pathology +17